Jennifer Kim

Stock Analyst at Cantor Fitzgerald

(3.09)
# 1,200
Out of 4,876 analysts
35
Total ratings
51.43%
Success rate
11.05%
Average return

Stocks Rated by Jennifer Kim

Belite Bio
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $59.95
Upside: -
Precigen
May 15, 2025
Reiterates: Overweight
Price Target: n/a
Current: $1.42
Upside: -
Insmed
Feb 20, 2025
Reiterates: Overweight
Price Target: n/a
Current: $99.49
Upside: -
Fortress Biotech
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $1.82
Upside: -
EyePoint Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $9.64
Upside: -
Ocugen
Aug 31, 2023
Maintains: Overweight
Price Target: $2.5$2
Current: $0.98
Upside: +103.23%
Lipocine
Jul 27, 2023
Reiterates: Overweight
Price Target: $33
Current: $3.29
Upside: +903.04%
ProQR Therapeutics
May 17, 2023
Maintains: Overweight
Price Target: $5$4.5
Current: $2.04
Upside: +120.59%
Aytu BioPharma
May 17, 2022
Maintains: Overweight
Price Target: $220$100
Current: $2.08
Upside: +4,707.69%